ClinicalTrials.govpublic full text
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
leukemia, myelodysplastic syndromes, myelodysplastic/myeloproliferative diseases, refractory anemia with excess blasts, recurrent adult acute myeloid leukemia, untreated adult acute myeloid leukemia, secondary acute myeloid leukemia, de novo myelodysplastic syndromes, previously treated myelodysplastic syndromes, secondary myelodysplastic syndromes, myelodysplastic/myeloproliferative disease, unclassifiable, refractory anemia with ringed sideroblasts
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 873369
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.